A. Wong

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
A Wong, Anthony C. Wong, Anthony Wong
Publication record
22 papers · 984 citations · H-index 12

PAPERS

Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma PatientsTreated With Immune Checkpoint Inhibitors or Enfortumab Vedotin.
202313 citationsauthor #16
Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer
202315 citationsauthor #18
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane.
20209 citationsauthor #5
Abstract 6121: Using the chicken chorioallantoic membranein vivomodel to study metastatic kidney cancer: A novel drug screening approach with more sustainable patient-derived xenografts
20200 citationsauthor #4
Mouse- and patient-derived CAM xenografts for studying metastatic renal cell carcinoma.
20195 citationsauthor #3
Contrast agents for quantitative microCT of lung tumors in mice.
201319 citationsauthor #10
Abstract 2336: Assessment of mechanisms of action (MOAs) of the Fc-engineered integrin α5β1 targeting antibody PF-04605412 in human integrin α5 knock-in mice.
20131 citationsauthor #6
Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation
201342 citationsauthor #14
Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in KrasG12D-LSL mice
201224 citationsauthor #6
Cancer Therapy : Preclinical Biomarker and Pharmacologic Evaluation of the g-Secretase Inhibitor PF-03084014 in Breast Cancer Models
20120 citationsauthor #13
Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models
201267 citationsauthor #13
[18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells
201184 citationsauthor #17
Abstract LB-390: Antitumor efficacy of crizotinib (PF-02341066), a potent and selective ALK and c-Met RTK inhibitor, in EML4-ALK driven NSCLC tumors in vitro and in vivo
20114 citationsauthor #15
Abstract 4480: Combination of a PI3K/mTOR inhibitor and a MEK inhibitor at suboptimal dose significantly inhibits growth of lung adenocarcinoma tumors in KrasG12D-LSL mice
20110 citationsauthor #4
HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors.
2010322 citationsauthor #4
Abstract 1758: Preclinical assessment of using [18F]FLT-PET imaging as a surrogate proof-of-mechanism biomarker for early drug development candidates
20100 citationsauthor #10
Abstract 5218: γ-secretase inhibitor PF-03084014 impairs Notch signaling and induces antiangiogenic and antitumor effects in breast cancer models
20100 citationsauthor #9
Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
2010164 citationsauthor #6
PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity
201074 citationsauthor #8
Abstract 4483: Establishing patient-derived colorectal cancer stem cell models with aPIK3CAmutation for the development of inhibitory drugs as targeted therapies
20101 citationsauthor #12
PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts
200963 citationsauthor #11
Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses.
200280 citationsauthor #5

TIMELINE

2002 80 citations

2009 63 citations

2010 561 citations

2011 88 citations

2012 91 citations

2013 62 citations

2019 5 citations

2020 9 citations

2023 28 citations

A. Wong

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT